NCT05144529 2025-04-17
TOP2101
Duke University
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT04937413 2024-06-25
The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation
Duke University
Phase EARLY_PHASE1 Completed
NCT04862260 2024-05-22
Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma
CHU de Quebec-Universite Laval
Phase EARLY_PHASE1 Active not recruiting
NCT05976893 2023-08-04
Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer
Xinjiang Medical University
Phase 4 Unknown